Apposite Capital, the private equity firm with an exclusive focus on healthcare, has acquired Swanton Care & Community Ltd (Swanton), a provider of residential and supported living care for adults with complex learning disabilities, mental health disorders and acquired brain injuries.
Apposite plans to further grow and develop the business through investment in both organic growth and acquisitions. Financial terms of the transaction are not disclosed.
Established in 2006, Swanton operates 24 specialist residential care homes, providing 259 registered beds across East Anglia, The West Midlands and South West Wales, the North East and Scotland. Swanton also provides a growing supported living service in its key localities. The company employs around 780 people and generated GBP25m revenues in the year end 31 December 2016.
The specialist care market is highly fragmented with a large number of providers of various shapes and sizes. In the UK, the provision of residential care and supported living services for people with learning disabilities represents approx. GBP6.6 billion of spend.
David Porter, Managing Partner, and Sam Gray, Partner, of Apposite Capital, are joining the Board of Directors while Dr Jerry Bereika will become Chairman. Jerry has more than 35 years of experience in the planning and delivery of health and care services. He was the Founder and CEO of Lifeways Community Care and served on the Board of By the Bridge, a previous Apposite portfolio company.
Gray, says: “We are very pleased to have been able to acquire Swanton as given the shortage of quality providers in some areas of the country we have been looking to invest in the complex residential and supported living care market for some time. Swanton has well-established relationships with Local Authorities and CCGs nationally and is well-regarded as a provider for those with more complex care needs. It represents an ideal platform to further develop the care services it offers to people and expand its offering in other areas of the country.”
This represents the 3rd new investment for Apposite this year and is the 4th investment from Apposite Healthcare Fund II.
